Ran Y - Search Results

1

Associations of C-reactive protein to lymphocyte ratio and metabolic-dysfunction-associated steatotic liver disease: evidence from NHANES 2017-2018.

Liu B, Sun X, Li X, Lu F, Xing G, Ma G, Ran Y, Hu SP. Liu B, et al. Among authors: ran y. BMC Gastroenterol. 2024 Dec 24;24(1):475. doi: 10.1186/s12876-024-03458-7. BMC Gastroenterol. 2024. PMID: 39719591 Free PMC article.

2

Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials.

Lu F, Zhao K, Ye M, Xing G, Liu B, Li X, Ran Y, Wu F, Chen W, Hu S. Lu F, et al. Among authors: ran y. BMC Cancer. 2024 Aug 19;24(1):1023. doi: 10.1186/s12885-024-12780-y. BMC Cancer. 2024. PMID: 39160484 Free PMC article.

3

In silico and in vivo verification of the mechanism of formononetin in treating hepatocellular carcinoma.

Ma G, Pang X, Ran Y, Chen W, Zhou Y, Li X, Liu B, Li F, Hu S. Ma G, et al. Among authors: ran y. Ann Med. 2024 Dec;56(1):2404550. doi: 10.1080/07853890.2024.2404550. Epub 2024 Sep 20. Ann Med. 2024. PMID: 39301883 Free PMC article.

4

Exploring causal associations between dietary intake and liver diseases: A bidirectional Mendelian randomization study.

Wang H, Yun Z, Li L, Wang H, Zeng H, Ran Y. Wang H, et al. Among authors: ran y. Medicine (Baltimore). 2024 Nov 8;103(45):e40095. doi: 10.1097/MD.0000000000040095. Medicine (Baltimore). 2024. PMID: 39533573 Free PMC article.

5

Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Lin S, Hu S, Ran Y, Wu F. Lin S, et al. Among authors: ran y. Transl Cancer Res. 2021 Apr;10(4):1667-1678. doi: 10.21037/tcr-20-3237. Transl Cancer Res. 2021. PMID: 35116492 Free PMC article.

6

[Retracted] MicroRNA‑326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.

Hu S, Ran Y, Chen W, Zhang Y, Xu Y. Hu S, et al. Among authors: ran y. Oncol Rep. 2023 May;49(5):87. doi: 10.3892/or.2023.8524. Epub 2023 Mar 17. Oncol Rep. 2023. PMID: 36928745 Free PMC article.

7

MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.

Hu S, Ran Y, Chen W, Zhang Y, Xu Y. Hu S, et al. Among authors: ran y. Oncol Rep. 2017 Sep;38(3):1569-1578. doi: 10.3892/or.2017.5810. Epub 2017 Jul 12. Oncol Rep. 2017. Retraction in: Oncol Rep. 2023 May;49(5):87. doi: 10.3892/or.2023.8524 PMID: 28713953 Retracted.

8

Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis.

Chen W, Liang F, Zhang Y, Zhang Y, Lv J, Jin X, Ran Y, Li S, Sun W. Chen W, et al. Among authors: ran y. Front Microbiol. 2024 Oct 25;15:1449090. doi: 10.3389/fmicb.2024.1449090. eCollection 2024. Front Microbiol. 2024. PMID: 39526142 Free PMC article.

9

A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.

Li L, Ye Y, Ran Y, Liu S, Tang Q, Liu Y, Liao X, Zhang J, Xiao G, Lu J, Zhang G, He Q, Hu S. Li L, et al. Among authors: ran y. Medicine (Baltimore). 2021 Apr 30;100(17):e25581. doi: 10.1097/MD.0000000000025581. Medicine (Baltimore). 2021. PMID: 33907107 Free PMC article.

10

Nek2B accelerates the progression of hepatocellular carcinoma through regulating SFRP1 to activate the Wnt/β-catenin pathway.

Li L, Ye Y, Ran Y, Zhou Y, Dang Z, Su X, Hu S. Li L, et al. Among authors: ran y. J BUON. 2021 May-Jun;26(3):861-867. J BUON. 2021. PMID: 34268946 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,227 results

Search Page

Filters